Amphotericin B dose optimization in children with malignant diseases.

Nath, Christa E; McLachlan, Andrew J; Shaw, Peter J; Coakley, John C; Earl, John W

Nath, Christa E; McLachlan, Andrew J; Shaw, Peter J; Coakley, John C; Earl, John W.

Affiliation

Nath CE; Department of Biochemistry, The Children's Hospital at Westmead, Westmead, Australia. Christan@chw.edu.au

Chemotherapy ; 53(2): 142-7, 2007.

Article in En | MEDLINE | ID: mdl-17310120

Subject(s)

Amphotericin B/administration & dosage; Antifungal Agents/administration & dosage; Deoxycholic Acid/administration & dosage; Kidney Diseases/prevention & control; Neoplasms/drug therapy; Adolescent; Amphotericin B/blood; Amphotericin B/pharmacokinetics; Antifungal Agents/blood; Antifungal Agents/pharmacokinetics; Body Weight; Child; Child, Preschool; Computer Simulation; Creatinine/blood; Cyclosporine/therapeutic use; Deoxycholic Acid/blood; Deoxycholic Acid/pharmacokinetics; Drug Combinations; Humans; Immunosuppressive Agents/therapeutic use; Infant; Kidney Diseases/etiology; Microbial Sensitivity Tests; Models, Biological; Mycoses/prevention & control; Neoplasms/blood; Risk Factors; Urea/blood; gamma-Glutamyltransferase/blood

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Amphotericin B / Deoxycholic Acid / Kidney Diseases / Antifungal Agents / Neoplasms Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Humans / Infant Language: En Year: 2007 Type: Article

Search on Google

XML

PubMed Links